Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.70 | 20.20 |
| PEG Ratio (TTM) | 0.00 | 10.34 |
| P/S Ratio (TTM) | 0.03 | 4.19 |
| P/B Ratio (TTM) | 0.06 | 4.96 |
| P/FCF Ratio (TTM) | 0.48 | 24.98 |
| Price to 5YR AVG Earnings Ratio | 2.00 | 58.14 |
| Price to 5YR AVG FCF Ratio | -1.22 | 47.38 |
Profitability (3%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -7.59% | -51.87% |
| ROE (TTM) | -15.92% | -0.90% |
| Net Profit Margin (TTM) | -4.62% | 5.42% |
| ROIC 5YR AVG | 0.59% | 16.37% |
Growth (85%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 298.06% | 292.22% | 154.77% |
| Revenue | -6.40% | 10.66% | 6.31% |
| Net Income | 292.68% | 313.04% | 173.10% |
| Cash Flow | 262.29% | 218.97% | 126.76% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.16 | 2.18 |
| Quick Ratio (TTM) | 0.32 | 1.51 |
| D/E Ratio (TTM) | 0.39 | 0.61 |
| Interest Coverage (TTM) | 0.13 | 5.65 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | 1.84 | 5.89 |
| LTL to 5YR AVG FCF | -1.29 | 4.59 |
| Shares Outstanding Growth 5YR AVG | 8.05% | 0.39% |